What are the different classes of antibiotics?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 1, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Major Antibiotic Classes

Antibiotics are organized into several major structural and mechanistic classes: β-lactams (including penicillins, cephalosporins, carbapenems, and monobactams), fluoroquinolones, macrolides/azalides, aminoglycosides, tetracyclines, glycopeptides, oxazolidinones, lincosamides, and sulfonamides. 1, 2

β-Lactam Antibiotics

The β-lactam class is characterized by a four-membered β-lactam ring that inhibits bacterial cell wall synthesis by binding to penicillin-binding proteins (PBPs), ultimately causing bacterial autolysis. 1, 3

Penicillins

  • Natural penicillins (penicillin G, penicillin V) are the treatment of choice for streptococcal infections, primarily targeting Gram-positive cocci including Streptococcus pneumoniae and Streptococcus pyogenes. 4

  • Penicillinase-resistant penicillins (dicloxacillin, nafcillin, flucloxacillin) specifically target methicillin-susceptible Staphylococcus aureus (MSSA). 4

  • Aminopenicillins (amoxicillin, ampicillin) represent the most active oral β-lactams against pneumococci due to excellent bioavailability, covering streptococci and some Gram-negative organisms like Escherichia coli and Proteus mirabilis. 1, 4

  • β-lactam/β-lactamase inhibitor combinations (amoxicillin-clavulanate, ampicillin-sulbactam, piperacillin-tazobactam) preserve β-lactam activity against β-lactamase-producing organisms. 1 Amoxicillin-clavulanate is the first-choice oral agent for skin/soft tissue infections, covering MSSA, streptococci, H. influenzae, Moraxella catarrhalis, and anaerobes. 4 Piperacillin-tazobactam has very broad spectrum including P. aeruginosa, Enterobacteriaceae, MSSA, streptococci, and anaerobes. 4

Cephalosporins

Cephalosporins are organized by generation, with modifications to broaden antimicrobial spectrum and increase β-lactamase stability. 1

  • First-generation (cefazolin, cephalexin) are most active against MSSA and streptococci, covering Klebsiella, E. coli, and P. mirabilis. 4

  • Second-generation (cefuroxime) provide expanded Gram-negative coverage. 1

  • Third-generation (ceftriaxone, cefotaxime, ceftazidime) offer broad Gram-negative coverage, with ceftazidime specifically covering Pseudomonas. 1

  • Fourth-generation (cefepime) provide enhanced activity against both Gram-positive and Gram-negative organisms including Pseudomonas. 1

Carbapenems

  • Carbapenems (ertapenem, meropenem, imipenem) provide the broadest antimicrobial spectrum of all β-lactams, covering essentially all pathogenic organisms except MRSA and vancomycin-resistant enterococci. 1, 4 Ertapenem (group 1 carbapenem) lacks Pseudomonas coverage, while meropenem and imipenem (group 2 carbapenems) cover Pseudomonas. 1

Monobactams

  • Monobactams (aztreonam) are activated by sulfonic, phosphoric, or carboxyl groups and possess β-lactamase stability related to their C-4 grouping. 3

Fluoroquinolones

Fluoroquinolones (ciprofloxacin, levofloxacin, moxifloxacin, gatifloxacin) provide broad-spectrum activity for respiratory, urinary, and gastrointestinal infections. 1, 2 Respiratory fluoroquinolones (levofloxacin, moxifloxacin, gatifloxacin) have the greatest in vitro activity against predominant respiratory pathogens, with 99% activity against S. pneumoniae. 1

Macrolides and Azalides

Macrolides (erythromycin, clarithromycin) and azalides (azithromycin) are effective for respiratory infections, particularly community-acquired pneumonia, due to their effectiveness against Gram-positive bacteria and atypical pathogens. 1, 2 They demonstrate 63-75% activity against S. pneumoniae and 100% activity against M. catarrhalis. 1

Aminoglycosides

Aminoglycosides (gentamicin, tobramycin, amikacin) are often used in combination with β-lactams for serious Gram-negative infections, including Pseudomonas aeruginosa. 2

Tetracyclines

Tetracyclines (doxycycline, minocycline) are recommended for atypical infections, rickettsial diseases, and some skin infections. 2 Doxycycline demonstrates 25% activity against H. influenzae and 78-96% activity against M. catarrhalis. 1

Glycopeptides

Glycopeptides (vancomycin, teicoplanin) are reserved for serious infections with resistant Gram-positive bacteria, including MRSA, and are active exclusively against Gram-positive organisms. 1, 2, 4

Oxazolidinones

Oxazolidinones (linezolid) are effective for MRSA and VRE infections due to their unique mechanism of action and effectiveness against resistant Gram-positive bacteria. 2, 4

Lincosamides

Lincosamides (clindamycin) are bacteriostatic against Gram-positive organisms including MSSA, S. pneumoniae, and S. pyogenes, useful for impetigo, purulent skin/soft tissue infections, and necrotizing fasciitis. 1, 4 Clindamycin demonstrates 90-92% activity against S. pneumoniae. 1

Sulfonamides

Sulfonamides (trimethoprim-sulfamethoxazole) demonstrate 63-75% activity against S. pneumoniae, 70-85% activity against H. influenzae, and 20% activity against M. catarrhalis. 1

Common Pitfall

Cephalosporins are inherently less active than penicillin/amoxicillin against S. pneumoniae, with baseline MICs fourfold higher than amoxicillin, and their active absorption in the gastrointestinal tract limits achievable concentrations regardless of dose. 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Antibiotic Categories and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Antibiotic Spectrum and Clinical Applications

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.